» Articles » PMID: 15838520

SCF-mediated Protein Degradation and Cell Cycle Control

Overview
Journal Oncogene
Date 2005 Apr 20
PMID 15838520
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

The regulatory step in ubiquitin (Ub)-mediated protein degradation involves recognition and selection of the target substrate by an E3 Ub-ligase. E3 Ub-ligases evoke sophisticated mechanisms to regulate their activity temporally and spatially, including multiple post-translational modifications, combinatorial E3 Ub-ligase pathways, and subcellular localization. The phosphodegrons of many substrates incorporate the activities of multiple kinases, and ubiquitination only occurs when all necessary phosphorylation signals have been incorporated. In this manner, the precise timing of degradation can be controlled. Another way that the Ub pathway tightly controls the timing of proteolysis is with multiple E3 Ub-ligases acting upon a single target. Lastly, subcellular localization can either promote or prevent degradation by regulating the accessibility of kinases and E3 Ub-ligases. This review highlights recent findings that exemplify these emerging themes in the regulation of E3 Ub-ligase substrate recognition.

Citing Articles

HSC70 coordinates COP9 signalosome and SCF ubiquitin ligase activity to enable a prompt stress response.

Nishimura S, Kioka H, Ding S, Hakui H, Shinomiya H, Tanabe K EMBO Rep. 2025; 26(5):1344-1366.

PMID: 39915298 PMC: 11894141. DOI: 10.1038/s44319-025-00376-x.


p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells.

Majewska J, Agrawal A, Mayo A, Roitman L, Chatterjee R, Sekeresova Kralova J Nat Cell Biol. 2024; 26(8):1336-1345.

PMID: 39103548 PMC: 11321988. DOI: 10.1038/s41556-024-01465-0.


Proteomic analysis reveals a PLK1-dependent G2/M degradation program and a role for AKAP2 in coordinating the mitotic cytoskeleton.

Mouery R, Lukasik K, Hsu C, Bonacci T, Bolhuis D, Wang X Cell Rep. 2024; 43(8):114510.

PMID: 39018246 PMC: 11403584. DOI: 10.1016/j.celrep.2024.114510.


The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.

Rong Z, Zheng K, Chen J, Jin X J Cancer Res Clin Oncol. 2024; 150(3):154.

PMID: 38521878 PMC: 10960765. DOI: 10.1007/s00432-024-05659-9.


Differential genomic effects of four nano-sized and one micro-sized CeO particles on HepG2 cells.

Thai S, Jones C, Robinette B, Ren H, Vallanat B, Fisher A Mater Express. 2023; 13(10):1799-1811.

PMID: 38009104 PMC: 10667950. DOI: 10.1166/mex.2023.2527.